Phase 2 Acute Lymphoblastic Leukemia, Adult Clinical Trials
7 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–7 of 7 trials
Recruiting
Phase 2
CAR T-cell Therapy in Patients With Renal Dysfunction
Multiple MyelomaAcute Lymphoblastic Leukemia, AdultNon-hodgkin Lymphoma,B Cell
Northside Hospital, Inc.20 enrolled1 locationNCT05909059
Recruiting
Phase 1Phase 2
Fourth-gen CAR T Cells Targeting CD19/CD22 for Highly Resistant B-cell Lymphoma/Leukemia (PMBCL/CNS-BCL).
Acute Lymphoblastic Leukemia, Adult B-CellAcute Lymphoblastic Leukemia, in Relapse
Essen Biotech75 enrolled1 locationNCT06213636
Recruiting
Phase 2Phase 3
Multicenter Study of Combined Chemotherapy and Transplantation for Adult ALL
Acute Lymphoblastic Leukemia, Adult
Shanxi Bethune Hospital50 enrolled1 locationNCT07059156
Recruiting
Phase 1Phase 2
CD19 CAR-T Consolidation Therapy for Acute Lymphoblastic Leukemia
Acute Lymphoblastic Leukemia, Adult B-Cell
The First Affiliated Hospital of Soochow University34 enrolled1 locationNCT03984968
Recruiting
Phase 2
A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditioning Regimen for Adult ALL
Acute Lymphoblastic Leukemia, Adult
The First Affiliated Hospital of Zhengzhou University170 enrolled1 locationNCT06557161
Recruiting
Phase 2
A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Conditioning Regimen for Adult ALL
Acute Lymphoblastic Leukemia, Adult
The First Affiliated Hospital of Zhengzhou University276 enrolled1 locationNCT06564545
Recruiting
Phase 1Phase 2
Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR
Diffuse Large B Cell LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+3 more
University Hospital Heidelberg68 enrolled2 locationsNCT03676504